Harvard Bioscience, Inc. (Nasdaq: HBIO) will release its financial results for the first quarter of 2025 on May 12, 2025, before the market opens, followed by a conference call at 8:00 a.m. Eastern ...

Harvard Bioscience ( (HBIO)) has provided an update. On December 17, 2025, Harvard Bioscience finalized a $40 million loan agreement with BroadOak Capital Partners to refinance its existing debt, ...

The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates ...

HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Monday reported a loss of $2.3 million in its second quarter. The Holliston, Massachusetts-based company said it had a ...

Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement. Analysts estimate that Harvard ...

Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being ...

Equities researchers at StockNews.com started coverage on shares of Harvard Bioscience (NASDAQ:HBIO – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating ...

Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flexibility BroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board ...

Harvard Bioscience, the lab equipment manufacturer based in Holliston, has signed a distribution agreement with Fisher Scientific, the large life science and clinical research firm based in Waltham.

HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Monday reported a loss of $50.3 million in its first quarter. The Holliston, Massachusetts-based company said it had a ...